While systematic inhibition of thrombin could interrupt TGF-β1 releasate from platelet and improve antitumor immunity of the tumor mircroenvironment during immunotherapy24.Therefore, SERPIND1 might play anti-tumor role through inhibiting thrombin, and it is discovered to be under-expression in EC in this study. Here, TGFB1 is linked to neoplasm.